Spectrofluorimetric analysis of fingolimod via complex formation with eosin Y in its pure form, pharmaceutical preparation and biological samples

被引:6
作者
Salem, Hesham [1 ]
Elsoud, Fatma A. Abo [1 ]
Heshmat, Dina [1 ]
机构
[1] Deraya Univ, Fac Pharm, Pharmaceut Chem Dept, New Minia, Egypt
关键词
Fingolimod; Eosin Y; Capsules; Biological samples; Spectrofluorometry;
D O I
10.1016/j.saa.2020.119331
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
This work discuss a simple, rapid, accurate, precise, sensitive, validated and effective cost spectrofluorometric method. The technique was applied for the analysis of fingolimod hydrochloride (FIN) in pure form, capsules, human plasma and urine samples. Formation of binary complex between the suggested amino group of (FIN) with Eosin Y (EOY) is the principle of its determination. FIN was determined spectrofluorimetrically by measuring its quenching effect on the EOY native fluorescence at 575 nm after excitation at 525 nm. The fluorescence-concentration linearity was 0.1-1.0 mg mL(-1). The suggested spectrofluorimetric results have been certified according to ICH regulations and were applied for analysis of FIN in capsules, human plasma and urine samples. The validated results were accepted compared to reference method. (C) 2020 Elsevier B.V. All rights reserved.
引用
收藏
页数:5
相关论文
共 33 条
[1]   Xanthene based spectroscopic probe for the analysis of HCV antiviral, daclatasvir dihydrochloride, through feasible complexation reaction [J].
Abdel-Lateef, Mohamed A. ;
Omar, Mahmoud A. ;
Ali, Ramadan ;
Derayea, Sayed M. .
MICROCHEMICAL JOURNAL, 2019, 145 :672-675
[2]   Spectrofluorimetric determination of thioridazine and flupentixol in dosage forms; application to content uniformity test [J].
Attia, Tamer Z. ;
Omar, Mahmoud A. .
LUMINESCENCE, 2016, 31 (05) :1091-1097
[3]   Mixed hemimicelles solid-phase extraction based on sodium dodecyl sulfate (SDS)-coated nano-magnets for the spectrophotometric determination of Fingolomid in biological fluids [J].
Azari, Zhila ;
Pourbasheer, Eslam ;
Beheshti, Abolghasem .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2016, 153 :599-604
[4]   Utility of eosin Y as a complexing reagent for the determination of citalopram hydrobromide in commercial dosage forms by fluorescence spectrophotometry [J].
Azmi, Syed Najmul Hejaz ;
Al-Fazari, Ahlam ;
Al-Badaei, Munira ;
Al-Mahrazi, Ruqiya .
LUMINESCENCE, 2015, 30 (08) :1352-1359
[5]   The immune modulator FTY720 targets sphingosine 1-phosphate receptors [J].
Brinkmann, V ;
Davis, MD ;
Heise, CE ;
Albert, R ;
Cottens, S ;
Hof, R ;
Bruns, C ;
Prieschl, E ;
Baumruker, T ;
Hiestand, P ;
Foster, CA ;
Zollinger, M ;
Lynch, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21453-21457
[6]   Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis [J].
Brinkmann, Volker ;
Billich, Andreas ;
Baumruker, Thomas ;
Heining, Peter ;
Schmouder, Robert ;
Francis, Gordon ;
Aradhye, Shreeram ;
Burtin, Pascale .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (11) :883-897
[7]  
Chhabda P.J., 2013, Pharmanest, V4, P1206
[8]   FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors [J].
Chiba, K .
PHARMACOLOGY & THERAPEUTICS, 2005, 108 (03) :308-319
[9]  
Derayea S., 2016, Anal. Chem. Lett., V6, P508
[10]   Studying the association complex formation of atomoxetine and fluvoxamine with eosin Y and its application in their fluorimetric determination [J].
Derayea, Sayed M. ;
Omar, Mahmoud A. ;
Abu-Hassan, Ahmed A. .
ROYAL SOCIETY OPEN SCIENCE, 2018, 5 (03)